104 related articles for article (PubMed ID: 22234102)
1. Sodium iodide symporter, estrogen receptor, and progesterone receptor expression in carcinoma breast--an immunohistochemical analysis.
Tandon A; Shrivastava A; Kumar A; Prayaga AK; Sundaram C; Godbole MM
Indian J Pathol Microbiol; 2011; 54(4):745-51. PubMed ID: 22234102
[TBL] [Abstract][Full Text] [Related]
2. Correlation of clinicopathological features and expression of molecular markers with prognosis after ¹³¹I treatment of differentiated thyroid carcinoma.
Qin C; Cau W; Zhang Y; Mghanga FP; Lan X; Gao Z; An R
Clin Nucl Med; 2012 Mar; 37(3):e40-6. PubMed ID: 22310269
[TBL] [Abstract][Full Text] [Related]
3. Human sodium iodide symporter (hNIS) in fibroadenoma breast--a immunohistochemical study.
Rai R; Shrivastava A; Tandon A; Godbole MM; Kumar S; Das V; Dwivedi V; Pal L
Indian J Exp Biol; 2011 Feb; 49(2):113-7. PubMed ID: 21428212
[TBL] [Abstract][Full Text] [Related]
4. Endogenous NIS expression in triple-negative breast cancers.
Renier C; Yao C; Goris M; Ghosh M; Katznelson L; Nowles K; Gambhir SS; Wapnir I
Ann Surg Oncol; 2009 Apr; 16(4):962-8. PubMed ID: 19184238
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity.
Bhargava V; Kell DL; van de Rijn M; Warnke RA
Am J Pathol; 1994 Sep; 145(3):535-40. PubMed ID: 8080038
[TBL] [Abstract][Full Text] [Related]
6. [Estrogen and progesterone receptors of primary breast carcinoma and their axillary lymph node metastases--immunohistochemical investigations of routine formalin-fixed paraffin-embedded tissue].
Schulze MH; Buchmann J
Zentralbl Gynakol; 2000; 122(2):92-5. PubMed ID: 10721188
[TBL] [Abstract][Full Text] [Related]
7. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
[TBL] [Abstract][Full Text] [Related]
8. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical comparison between GCDFP-15 and estrogen and progesterone receptors in the diagnosis of metastatic carcinoma of the breast].
Villarroel Salinas J; Ortiz Hidalgo C; Soria Céspedes D
Gac Med Mex; 2012; 148(3):213-7. PubMed ID: 22820353
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal immunohistochemical expression of sodium/iodide symporter and hexokinase I in primary thyroid tumors with synchronous cervical metastasis.
Jung YH; Hah JH; Sung MW; Kim KH; Cho SY; Jeon YK
Laryngoscope; 2009 Mar; 119(3):541-8. PubMed ID: 19235753
[TBL] [Abstract][Full Text] [Related]
12. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
[TBL] [Abstract][Full Text] [Related]
13. Expression of androgen, estrogen and progesterone receptors in mucinous carcinoma of the breast.
Cho LC; Hsu YH
Kaohsiung J Med Sci; 2008 May; 24(5):227-32. PubMed ID: 18508419
[TBL] [Abstract][Full Text] [Related]
14. [Steroid hormone receptors in mammary carcinoma. Immunohistochemical detection and prognostic significance].
Reiner A; Neumeister B; Reiner G; Jakesz R; Kolb R; Schemper M; Spona J
Zentralbl Pathol; 1991; 137(3):233-41. PubMed ID: 1657132
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and progesterone receptors in primary eccrine carcinoma.
Voytek TM; Ricci A; Cartun RW
Mod Pathol; 1991 Sep; 4(5):582-5. PubMed ID: 1661896
[TBL] [Abstract][Full Text] [Related]
16. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
Van Calster B; Vanden Bempt I; Drijkoningen M; Pochet N; Cheng J; Van Huffel S; Hendrickx W; Decock J; Huang HJ; Leunen K; Amant F; Berteloot P; Paridaens R; Wildiers H; Van Limbergen E; Weltens C; Timmerman D; Van Gorp T; Smeets A; Van den Bogaert W; Vergote I; Christiaens MR; Neven P
Breast Cancer Res Treat; 2009 Jan; 113(1):181-7. PubMed ID: 18264760
[TBL] [Abstract][Full Text] [Related]
17. [Loss of hormonal receptors expression from primary breast carcinoma to axillary lymph node metastases].
Cianga C; Cianga P; Cozma L; Diaconu C; Carasevici E
Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):540-4. PubMed ID: 14756058
[TBL] [Abstract][Full Text] [Related]
18. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients.
Aryandono T; Harijadi ; Ghozali A
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical characteristics of mammary carcinomas with estrogen-negative and progesterone-positive receptors].
Sundblad AS; Caprarulo L
Medicina (B Aires); 1996; 56(6):683-9. PubMed ID: 9284572
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study.
Wilbur DC; Barrows GH
Mod Pathol; 1993 Mar; 6(2):114-20. PubMed ID: 8097877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]